This statistic depicts the number of clinical trials authorized by the Italian Medicines Agency in 2019, broken down by type of drug. According to the source, 385 of the trials were based on chemical active ingredients, whereas 24 of them were based on advanced therapy investigational medicinal products (ATIMP).
Number of clinical trials authorized by the Italian Medicines Agency in 2019, by type of drug
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Number of clinical trials for rare diseases in Italy by type of drug 2019
- Number of clinical trials in Italy by phase 2019
- Share of clinical trials out of total EU trials in Italy 2013-2019
- Percent of clinical studies with posted results worldwide by type 2022
- Alzheimer's disease clinical trials started worldwide from 2008-2017, by phase
- Alzheimer's disease clinical trials with select modalities worldwide as of 2019
- Obesity drugs clinical pipeline U.S. 2018, by type and phase
- Number of disease-modifying Alzheimer's drug trials globally in 2019, by strategy
- Number Alzheimer's drug trials globally in 2019, by category and phase
- Number of symptom-modifying Alzheimer's drug trials globally in 2019, by strategy
- Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
- Clinical trial costs by select component and phase
- Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication
- Clinical trial sites by country development status from 2006 to 2012
- Drug spending in the U.S. 2013-2017, by specialty and orphan status
- Global osteoporosis drug market share 2014-2022, by drug type
- Methods to contact research centers for clinical trials participation 2015
- Reasons patients did not participate in clinical trials globally 2017
- Clinical research study types that patients participated in worldwide 2017
- Presumed risks of participating in clinical research among adults worldwide in 2019
Agenzia Italiana del Farmaco. (December 30, 2020). Number of clinical trials authorized by the Italian Medicines Agency in 2019, by type of drug [Graph]. In Statista. Retrieved June 25, 2022, from https://www.statista.com/statistics/911594/number-of-clinical-trials-by-type-of-drug-in-italy/
Agenzia Italiana del Farmaco. "Number of clinical trials authorized by the Italian Medicines Agency in 2019, by type of drug." Chart. December 30, 2020. Statista. Accessed June 25, 2022. https://www.statista.com/statistics/911594/number-of-clinical-trials-by-type-of-drug-in-italy/
Agenzia Italiana del Farmaco. (2020). Number of clinical trials authorized by the Italian Medicines Agency in 2019, by type of drug. Statista. Statista Inc.. Accessed: June 25, 2022. https://www.statista.com/statistics/911594/number-of-clinical-trials-by-type-of-drug-in-italy/
Agenzia Italiana del Farmaco. "Number of Clinical Trials Authorized by The Italian Medicines Agency in 2019, by Type of Drug." Statista, Statista Inc., 30 Dec 2020, https://www.statista.com/statistics/911594/number-of-clinical-trials-by-type-of-drug-in-italy/
Agenzia Italiana del Farmaco, Number of clinical trials authorized by the Italian Medicines Agency in 2019, by type of drug Statista, https://www.statista.com/statistics/911594/number-of-clinical-trials-by-type-of-drug-in-italy/ (last visited June 25, 2022)